NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002026

Registered date:01/06/2009

Clinical study for the first relapsed ALL in children. JPLSG ALL-R08-I: Prospective observational study

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedfirst relapsed acute lymphoblastic leukemia in children
Date of first enrollment2009/06/01
Target sample size88
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary Outcome3 year-event free survival rate(3y-EFS), 3 year-overall survival rate(3y-OS)
Secondary Outcome

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximum20years-old
GenderMale and Female
Include criteria1. first relapsed ALL 2. Be<18 year old at initial diagnosis and be <20 year old at the enrollment 3. Parents(or leagal guardians) must provide signed, written informed consent.
Exclude criteriaPatients with mature B-ALL, Ph chromosome positive ALL or MLL gene rearrangement positive ALL.

Related Information

Contact

public contact
Name Akiko Saito
Address National Nagoya Hospital, 4-1-1, Sannomaru, Naka-ku, Nagoya Japan
Telephone 052-951-1111(2751)
E-mail nsgdata@nnh.hosp.go.jp
Affiliation Japanese Pediatric Leukemia/Lymphoma study Group Data Center
scientific contact
Name Chitose Ogawa
Address 5-1-1, Tsukiji, Chuo-ku, Tokyo Japan
Telephone 03-3542-2511
E-mail chitoseo@qb3.so-net.ne.jp
Affiliation National Cancer Center Hospital Department of Pediatric Oncology